January 18 2018
, Written by HarNeedi
Published on
#Drug research and development, #Healthcare in india, #Indian pharmaceutical companies, #Pharma companies, #Pharma industries, #Budget parivarthan, #drug companies, #Budget privarthan changes, #Drugs and Cosmetics, #medical devices, #use of generic medicines, #Medical Council of India, #MCI, #Indian Drug Industries, #generic drugs, #Indian drug manufacturing, #Indian drug production, #minister budget speech, #global pharmaceutical companies, #pharmaceutical production, #drugs and pharmaceutical exports, #pharma industry
The Government of India contrives to amend the Drugs and Cosmetics (D&C) rules to assure availability of medicines at reasonable costs and use of generic medicines, the finance minister (FM) proclaimed in the union budget for 2017-2018. New rules will...